ACT EU webinar on draft guidance on the conduct of clinical trials during public health emergencies, Online, from 8 April 2026, 10:00 (CEST) to 8 April 2026, 11:30 (CEST)

Human medicines European public assessment report (EPAR): Zolsketil pegylated liposomal, doxorubicin, Date of authorisation: 31/05/2022, Revision: 5, Status: Authorised

Levamisole

Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Date of authorisation: 18/07/2025, Revision: 1, Status: Authorised

Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, from 6 May 2026, 10:00 (CEST) to 6 May 2026, 11:30 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - June 2026, Online, from 10 June 2026, 15:30 (CEST) to 10 June 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - July 2026, Online, from 8 July 2026, 15:30 (CEST) to 8 July 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - September 2026, Online, from 9 September 2026, 15:30 (CEST) to 9 September 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - October 2026, Online, from 7 October 2026, 15:30 (CEST) to 7 October 2026, 16:00 (CEST)

Q&A clinic on Substance, Organisation, Referentials Management Services - November 2026, Online, from 11 November 2026, 15:30 (CET) to 11 November 2026, 16:00 (CET)